Literature DB >> 4919003

Pharmacokinetic interpretation of penicillin levels in serum and urine after intravenous administration.

L W Dittert, W O Griffen, J C LaPiana, F J Shainfeld, J T Doluisio.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 4919003

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother (Bethesda)


× No keyword cloud information.
  15 in total

Review 1.  Critical compilation of terminal half-lives, percent excreted unchanged, and changes of half-life in renal and hepatic dysfunction for studies in humans with references.

Authors:  L A Pagliaro; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1975-10

2.  Potential source of error in absorption rate calculations.

Authors:  H G Boxenbaum; S A Kaplan
Journal:  J Pharmacokinet Biopharm       Date:  1975-08

3.  Drug kinetics and artificial kidneys.

Authors:  T B Gibson; H A Nelson
Journal:  Clin Pharmacokinet       Date:  1977 Nov-Dec       Impact factor: 6.447

Review 4.  Protein binding of antimicrobials: clinical pharmacokinetic and therapeutic implications.

Authors:  W A Craig; P G Welling
Journal:  Clin Pharmacokinet       Date:  1977 Jul-Aug       Impact factor: 6.447

Review 5.  Clinical pharmacology of antibiotics and other drugs in cystic fibrosis.

Authors:  J Prandota
Journal:  Drugs       Date:  1988-05       Impact factor: 9.546

6.  Butylbiguanide concentration in plasma, liver, and intestine after intravenous and oral administration to man.

Authors:  W Lintz; W Berger; W Aenishaenslin; V Kutova; C Baerlocher; J P Kapp; R Beckmann
Journal:  Eur J Clin Pharmacol       Date:  1974-10-04       Impact factor: 2.953

7.  [Pharmacokinetics of azlocillin, a new semisynthetic, wide-spectrum antibiotic (author's transl)].

Authors:  K Wirth; M Schomerus; J H Hengstmann
Journal:  Infection       Date:  1976       Impact factor: 3.553

8.  Comparative clinical pharmacology of amoxicillin and ampicillin administered orally.

Authors:  C Gordon; C Regamey; W M Kirby
Journal:  Antimicrob Agents Chemother       Date:  1972-06       Impact factor: 5.191

9.  The pharmacokinetics of furazlocillin in healthy humans.

Authors:  P H Hinderling; U Gundert-Remy; D Förster; W Gau
Journal:  J Pharmacokinet Biopharm       Date:  1983-02

10.  The metabolic disposition of flucloxacillin in patients with impaired kidney function.

Authors:  H H Thijssen; J Wolters
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.